Results 81 to 90 of about 364,170 (283)
Analysis of a model for hepatitis C virus transmission that includes the effects of vaccination with waning immunity [PDF]
arXiv, 2017 This paper considers a mathematical model based on the transmission dynamics of hepatitis C virus (HCV) infection. In addition to the usual compartments for susceptible, exposed, and infected individuals, this model includes compartments for individuals who are under treatment and those who have had vaccination against HCV infection. It is assumed that
arxiv
Speeding up disease extinction with a limited amount of vaccine [PDF]
, 2009 We consider optimal vaccination protocol where the vaccine is in short supply. In this case, disease extinction results from a large and rare fluctuation. We show that the probability of such fluctuation can be exponentially increased by vaccination. For periodic vaccination with fixed average rate, the optimal vaccination protocol is model independent
arxiv +1 more source
(Mis)perceptions and Engagement on Twitter: COVID-19 Vaccine Rumors on Efficacy and Mass Immunization Effort [PDF]
arXiv, 2021 This paper reports the findings of a 606-participant study where we analyzed the perception and engagement effects of COVID-19 vaccine rumours on Twitter pertaining to (a) vaccine efficacy; and (b) mass immunization efforts in the United States. Misperceptions regarding vaccine efficacy were successfully induced through simple content alterations and ...
arxiv
Journal of the Peripheral Nervous System, Volume 27, Issue 4, Page 325-329, December 2022., 2022 Abstract Small fiber neuropathy usually presents with gradual and progressive chronic length‐dependent pain. Acute small fiber neuropathy is rarely reported. Three patients with acute onset neuropathic pain after Oxford‐AstraZeneca ChAdOx1‐S vaccination are described.
Molly G. Abbott +10 more
wiley +1 more source
BMC Research Notes, 2018 Objectives The study was conducted to assess the knowledge on HBV vaccine and vaccination status among health care workers of Hawassa University Comprehensive Specialized Hospital.
Asres Bedaso, Bereket Duko, Remla Fedlu
doaj +1 more source
Serostatus Testing & Dengue Vaccine Cost-Benefit Thresholds [PDF]
, 2019 The World Health Organisation currently recommends pre-screening for past infection prior to administration of the only licensed dengue vaccine, CYD-TDV. Using a bounding analysis, we show that despite additional testing costs, this approach can improve the economic viability of CYD-TDV: effective testing reduces unnecessary vaccination costs while ...
arxiv +1 more source
Feminist Anthropology, EarlyView.Abstract Pre‐exposure prophylaxis (PrEP) is an antiretroviral drug that effectively prevents an HIV infection, which German statutory health insurance has covered since 2019. The drug's use in Germany has (re)surfaced ambivalent emotions: hopes for an HIV/AIDS‐free future and sexual liberation rub against enduring worries and moralizations of ...
Max Schnepf
wiley +1 more source
Food Safety and Health, EarlyView.This graphical abstract highlights the benefits of genetically modified (GM) foods, including high‐yield crops such as golden rice with enhanced nutrition, GM vaccines, and biofuel production. Advanced analytical methods ensure safety by detecting allergenicity and toxicity, promoting sustainability while addressing environmental impacts and balancing ...
Mohamad Warda +5 more
wiley +1 more source
Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review
Global Challenges, EarlyView.Silver nanoparticles (AgNPs) exhibit broad‐spectrum antiviral activity by targeting key viral structures and processes. They disrupt viral envelopes, compromising integrity, and bind to nucleocapsids, impairing viral replication. AgNPs also inhibit glycoprotein interactions, preventing viral attachment and entry into host cells.
Ekaterine Mosidze +8 more
wiley +1 more source
Journal of Viral Hepatitis, Volume 30, Issue 1, Page 46-55, January 2023., 2023 Abstract Most high‐income countries are not on track to achieve the World Health Organization hepatitis C elimination targets. As elimination programmes assess growing proportions of patients in community‐based pathways, rates of treatment uptake may fall.
Kathleen Bryce +3 more
wiley +1 more source